96 related articles for article (PubMed ID: 24244729)
1. Role of glucuronidation for hepatic detoxification and urinary elimination of toxic bile acids during biliary obstruction.
Perreault M; Białek A; Trottier J; Verreault M; Caron P; Milkiewicz P; Barbier O
PLoS One; 2013; 8(11):e80994. PubMed ID: 24244729
[TBL] [Abstract][Full Text] [Related]
2. Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
Gallucci GM; Trottier J; Hemme C; Assis DN; Boyer JL; Barbier O; Ghonem NS
Hepatol Commun; 2021 Dec; 5(12):2035-2051. PubMed ID: 34558841
[TBL] [Abstract][Full Text] [Related]
3. Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting.
Trottier J; Białek A; Caron P; Straka RJ; Milkiewicz P; Barbier O
PLoS One; 2011; 6(7):e22094. PubMed ID: 21760958
[TBL] [Abstract][Full Text] [Related]
4. Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis.
Kayashima A; Sujino T; Fukuhara S; Miyamoto K; Kubosawa Y; Ichikawa M; Kawasaki S; Takabayashi K; Iwasaki E; Kato M; Honda A; Kanai T; Nakamoto N
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780302
[TBL] [Abstract][Full Text] [Related]
5. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.
Alnouti Y; Csanaky IL; Klaassen CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 873(2):209-17. PubMed ID: 18801708
[TBL] [Abstract][Full Text] [Related]
6. Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury.
Truong JK; Bennett AL; Klindt C; Donepudi AC; Malla SR; Pachura KJ; Zaufel A; Moustafa T; Dawson PA; Karpen SJ
J Lipid Res; 2022 Sep; 63(9):100261. PubMed ID: 35934110
[TBL] [Abstract][Full Text] [Related]
7. A chemical derivatization-based pseudotargeted liquid chromatography-tandem mass spectrometry method for sensitive and high coverage determination of bile acids in human serum.
Xiong X; Gu X; Li X; Jia K; Wei Y; Zhao R
Anal Chim Acta; 2024 Jan; 1287():342119. PubMed ID: 38182391
[TBL] [Abstract][Full Text] [Related]
8. Perturbations in human bile acid profiles following drug-induced liver injury investigated using semitargeted high-resolution mass spectrometry.
Mireault M; Rose CF; Karvellas CJ; Sleno L
Rapid Commun Mass Spectrom; 2024 May; 38(9):e9731. PubMed ID: 38469943
[TBL] [Abstract][Full Text] [Related]
9. Development of Alcohol-Associated Hepatitis Is Associated With Specific Changes in Gut-Modified Bile Acids.
Muthiah MD; Smirnova E; Puri P; Chalasani N; Shah VH; Kiani C; Taylor S; Mirshahi F; Sanyal AJ
Hepatol Commun; 2022 May; 6(5):1073-1089. PubMed ID: 34984859
[TBL] [Abstract][Full Text] [Related]
10. Determination of bile acids in serum of pigs exposed to polychlorinated biphenyls by liquid chromatography-mass spectrometry.
Narduzzi L; Hernández-Mesa M; Le Bizec B; García-Campaña AM; Dervilly G
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123976. PubMed ID: 38141289
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for blood-to-brain influx of unconjugated bile acids by passive diffusion: Determination of their brain-to-serum concentration ratios in rats by LC/MS/MS.
Shibuya T; Sato A; Nishimoto-Kusunose S; Yoshizawa K; Higashi T
Steroids; 2024 Apr; 204():109397. PubMed ID: 38508483
[TBL] [Abstract][Full Text] [Related]
12. Circulating concentrations of bile acids and prevalent chronic kidney disease among newly diagnosed type 2 diabetes: a cross-sectional study.
Geng T; Lu Q; Jiang L; Guo K; Yang K; Liao YF; He M; Liu G; Tang H; Pan A
Nutr J; 2024 Mar; 23(1):28. PubMed ID: 38429722
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Characterization of Bile Acids in Human Biological Samples and Effect of 4-Week Strawberry Intake on Bile Acid Composition in Human Plasma.
Zhao A; Zhang L; Zhang X; Edirisinghe I; Burton-Freeman BM; Sandhu AK
Metabolites; 2021 Feb; 11(2):. PubMed ID: 33578858
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study.
Greimel A; Habler K; Gräfe C; Maciuga N; Brozat CI; Vogeser M; Zoller M; Happich FL; Liebchen U; Frank S; Paal M; Scharf C
Ann Intensive Care; 2023 Nov; 13(1):110. PubMed ID: 37943350
[TBL] [Abstract][Full Text] [Related]
15. Role of diet on non-alcoholic fatty liver disease: An updated narrative review.
Papandreou D; Andreou E
World J Hepatol; 2015 Mar; 7(3):575-82. PubMed ID: 25848481
[TBL] [Abstract][Full Text] [Related]
16. Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.
Roman S; Ojeda-Granados C; Ramos-Lopez O; Panduro A
World J Gastroenterol; 2015 Mar; 21(12):3449-61. PubMed ID: 25834309
[TBL] [Abstract][Full Text] [Related]
17. Bile acid signaling in metabolic disease and drug therapy.
Li T; Chiang JY
Pharmacol Rev; 2014 Oct; 66(4):948-83. PubMed ID: 25073467
[TBL] [Abstract][Full Text] [Related]
18. Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols.
Tveter KM; Mezhibovsky E; Wu Y; Roopchand DE
Pharmacol Ther; 2023 Aug; 248():108457. PubMed ID: 37268113
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of anti-proteolytic peptide R7I in intestinal inflammation, function, microbiota, and metabolites by multi-omics analysis in murine bacterial enteritis.
Sun T; Liu X; Su Y; Wang Z; Cheng B; Dong N; Wang J; Shan A
Bioeng Transl Med; 2023 Mar; 8(2):e10446. PubMed ID: 36925697
[TBL] [Abstract][Full Text] [Related]
20. Semi-Targeted Profiling of Bile Acids by High-Resolution Mass Spectrometry in a Rat Model of Drug-Induced Liver Injury.
Mireault M; Prinville V; Ohlund L; Sleno L
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
